Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration

Affiliations

• ¹ Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. Electronic address: david.parr@uhcw.nhs.uk.
• ² Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Disease, Warsaw, Poland.
• ³ Respiratory Diseases Division, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
• ⁴ Pneumology Department, Hospital Universitari Vall d'Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
• ⁵ Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.
• ⁶ Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
• ⁷ Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
• ⁸ Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, Sweden.
• ⁹ Institute for Applied Health Research, University of Birmingham, Birmingham, UK.